Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3y1 (Ala-Ala) in the treatment of acute renal allograff rejection

MLA

Woodie, E. S., et al. “Phase I Trial of a Humanized, Fc Receptor Nonbinding OKT3 Antibody, HuOKT3y1 (Ala-Ala) in the Treatment of Acute Renal Allograff Rejection.” Transplantation, vol. 68, no. 5, Sept. 1999, p. 608. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=2485589&authtype=sso&custid=ns315887.

APA

Woodie, E. S., Xu, D., Zivin, R. A., Auger, J., Charette, J., O’Laughlin, R., Peace, D., Jolliffe, L. K., Haverty, T., Bluestone, J. A., & Thistlethwaite, J. J. R. (1999). Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3y1 (Ala-Ala) in the treatment of acute renal allograff rejection. Transplantation, 68(5), 608.

Chicago

Woodie, E.S., D. Xu, R.A. Zivin, J. Auger, J. Charette, R. O’Laughlin, D. Peace, et al. 1999. “Phase I Trial of a Humanized, Fc Receptor Nonbinding OKT3 Antibody, HuOKT3y1 (Ala-Ala) in the Treatment of Acute Renal Allograff Rejection.” Transplantation 68 (5): 608. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=2485589&authtype=sso&custid=ns315887.